Skip to content

Released Nov 7, 2018, before the open

10-Q filed Nov 7, 2018, 38 days after period end · 0001144204-18-057761

Q3 2018 · 10-Q
Revenue$0.00— vs Q3 2017no prior Q2 2018 on file
Net Income-$2.46MN/M vs Q3 2017N/M vs Q2 2018
EPS Diluted-$0.12N/M vs Q3 2017N/M vs Q2 2018
Operating Income-$2,353,056N/M
Operating Cash Flowderived-$3,359,662N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2018Q3 2017Q3 2016Q3 2015
Revenue$0.00$0.00——
Net Income-$2.46M-$4.70M-$3.24M-$6.37M
EPS Diluted-$0.12-$0.22-$0.18-$0.35

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR